Cargando…

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA (2) DS (2)‐VASc Scores

BACKGROUND: The ABC‐stroke score (age, biomarkers [N‐terminal fragment B‐type natriuretic peptide, high‐sensitivity troponin], and clinical history [prior stroke/transient ischemic attack]) was proposed to predict stroke in atrial fibrillation (AF). This score was derived/validated in 2 clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivera‐Caravaca, José Miguel, Roldán, Vanessa, Esteve‐Pastor, María Asunción, Valdés, Mariano, Vicente, Vicente, Lip, Gregory Y. H., Marín, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586327/ https://www.ncbi.nlm.nih.gov/pubmed/28729407 http://dx.doi.org/10.1161/JAHA.117.006490

Ejemplares similares

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

The Association of CHA(2)DS(2)-VASc Score and Blood Biomarkers with Ischemic Stroke Outcomes: The Belgrade Stroke Study
por: Potpara, Tatjana S., et al.
Publicado: (2014)

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
por: Tomasdottir, Maria, et al.
Publicado: (2019)

Changes in CHA(2)DS(2)-VASc score and risk of ischemic stroke among patients with atrial fibrillation
por: Tsiartas, Eirinaios, et al.
Publicado: (2023)

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2017)

Stroke and Systemic Thromboembolism according to CHA(2)DS(2)-VASc Score in Contemporary Korean Patients with Atrial Fibrillation
por: Lee, Kyung Bae, et al.
Publicado: (2022)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

CHA2DS2-VASc score in acute ischemic stroke with atrial fibrillation: results from the Clinical Research Collaboration for Stroke in Korea
por: Lee, Hak-Loh, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study
por: Tiwari, Sweta, et al.
Publicado: (2016)

Predictors of stroke or systemic embolism in patients with non‐valvular atrial fibrillation with CHA(2)DS(2)‐VASc score of 0
por: Choi, Hyohun, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

CHADS(2), CHA(2)DS(2)-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study
por: Yu, Inwu, et al.
Publicado: (2021)

Left Ventricular Diastolic Function: The Link between CHA(2)DS(2)-VASc Score and Ischemic Stroke in Patients with Atrial Fibrillation
por: Cho, In-Jeong
Publicado: (2018)

Impact of carotid atherosclerosis in CHA(2)DS(2)-VASc-based risk score on predicting ischemic stroke in patients with atrial fibrillation
por: Cho, Dong-Hyuk, et al.
Publicado: (2021)

The impact of cigarette smoking in predicting stroke using CHADS(2) and CHA(2)DS(2)-VASc schemas
por: Zuo, Ming-Liang, et al.
Publicado: (2020)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Predicting stroke and death in patients with heart failure using CHA(2)DS(2)-VASc score in Asia
por: Son, Mi Kyoung, et al.
Publicado: (2019)

CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke
por: Su, Chun-Hung, et al.
Publicado: (2022)

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2019)

The determinants of stroke phenotypes were different from the predictors (CHADS(2 )and CHA(2)DS(2)-VASc) of stroke in patients with atrial fibrillation: a comprehensive approach
por: Oh, Semi, et al.
Publicado: (2011)

A data-driven cluster analysis of stroke phenotypes in Asian patients with atrial fibrillation: refinement of the CHA2DS2-VASc score
por: Hsu, J C, et al.
Publicado: (2023)

Similar thrombolysis outcomes in acute stroke patients with and without atrial fibrillation if pre-stroke CHA(2)DS(2)-VASc score is low: A retrospective study
por: Wu, Hung-Ming, et al.
Publicado: (2020)

Right Atrial Fluorodeoxyglucose Uptake Is a Risk Factor for Stroke and Improves Prediction of Stroke Above the CHA(2)DS(2)-VASc Score in Patients With Atrial Fibrillation
por: Wang, Bing, et al.
Publicado: (2022)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

CHADS(2) and CHA(2)DS(2)-VASc Scores Predict the Risk of Ischemic Stroke Outcome in Patients with Interatrial Block without Atrial Fibrillation
por: Wu, Jin-Tao, et al.
Publicado: (2017)

Left atrial function as a predictor of stroke or systemic embolism: Beyond the CHA(2)DS(2)‐VASc score
por: Murat, Bektas, et al.
Publicado: (2023)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

Predictive value of CHA(2)DS(2)-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant)
por: Gažová, Andrea, et al.
Publicado: (2019)

Association of CHA2DS2-VASc Score with Long-Term Incidence of New-Onset Atrial Fibrillation and Ischemic Stroke after Myocardial Infarction
por: Jaakkola, Samuli, et al.
Publicado: (2022)

Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA(2)DS(2)-VASc score in hemodialysis patients with non-valvular atrial fibrillation
por: Bel-Ange, Anat, et al.
Publicado: (2021)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA(2)DS(2)-VASc score
por: Yan, Shuangbing, et al.
Publicado: (2019)

The association of CHA(2)DS(2)-VASc score and carotid plaque in patients with non-valvular atrial fibrillation
por: Shang, Luxiang, et al.
Publicado: (2019)

The relationship of the serum endocan level with the CHA(2)DS(2)-VASc score in patients with paroxysmal atrial fibrillation
por: Ceyhun, Gökhan
Publicado: (2021)

Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients
por: Fang, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_egor6ha7cd1m0qo28qnpoenu56